Wings 4 Innovation facilitates the translation of biomedical innovation in Austria, focusing on supporting academic institutes and SMEs in drug discovery proposals.

Wings 4 Innovation

Optilingua provides linguistic and translation services, including legal, medical, business, financial, certified translations, website translations, voice over services, subtitles, interpreting, proofreading, and transcription.

Optilingua

IoThink Solutions offers an Internet of Things (IoT) platform that provides flexible and customized IoT solutions for system integrators, device makers, machine builders, and network operators. Self-described as innovative, it supports rapid deployment and interoperability.

IoThink Solutions

Lead Discovery Center is involved in transferring scientific research into the development of innovative medications to provide new therapeutic options for patients. It acts as a link between academic research and industry.

Lead Discovery Center

wings4innovation GmbH | 241 followers on LinkedIn. Subsidiary of KHAN Technology Transfer Fund I GmbH &amp; Co. KG  | wings4innovation and KHAN-I technology transfer fund provide a new translation and financing paradigm for innovative drug discovery proposals from Austrian academic institutes and SMEs.

wings4innovation GmbH (w4i) is a subsidiary of KHAN Technology Transfer Fund I GmbH &amp; Co. KG (KHAN-I).

wings4innovation GmbH

#Osteoarthritis is a painful, chronic joint disease. Supported by wings4innovation GmbH , the KHAN Technology Transfer Fund I is providing financial resources for a project with Vetmeduni in #Vienna . The aim of this project is to identify active substances for the regeneration of joint cartilage. In this article, LISAvienna provides insights into the early phase of this drug development project. Learn more about the project initiated by Florien Jenner, Head of the Equine University Clinic at the University of Veterinary Medicine, Vienna and Laboratory Manager Iris Gerner. Partners include Evercyte GmbH , TAmiRNA GmbH , Morphisto GmbH and the Joint Metabolome Facility of University of Vienna and Medizinische Universität Wien . Austria Wirtschaftsservice | LISA - Life Science Austria Tanja Spennlingwimmer | Johannes Sarx | Peter Nussbaumer | Florien Jenner | Nina Grötschl | Thomas Zauner | Lisa-Ariadne Schmidt | Matthias Hackl | Otto Kanzler | Regina Grillari | Elisabeth Semmelrock | Magdalena Mecking | Serife Arda | Dr. Juliane Brümmer | Christine Ruckenbauer photo: Canva

LISAvienna

🔬 Attention Vienna-based life sciences researchers! The #xbio entrepreneurship course is now open for applications! 🔬 Peter Nussbaumer , the Managing Director of wings4innovation GmbH , the Austrian subsidiary of the technology transfer fund KHAN Technology Transfer Fund I , is one of the distinguished speakers. He also oversees the drug discovery incubator Lead Discovery Center GmbH . With that Peter has been at the forefront of bridging #academicresearch and industrial applications in the field of #drugdiscovery . Don't miss the opportunity to learn from his invaluable insights! Join us in shaping the future of biomedical entrepreneurship. Sign up for the #xbio course today! Apply now at www.x-bio.at ! Application deadline is March 15th. #LifeSciences #Biomedical #Entrepreneurship #Vienna #DrugDiscovery #AcademicResearch #Innovation #Startup #ISTA xista science ventures xista innovation xista

🌟 Clear statement of #Austrian Universities for the continuation of wings4innovation GmbH / KHAN Technology Transfer Fund I 🌟 Austrian universities have experienced significant benefits - and still yielding advantages in translational research - from w4i and KHAN-I initiatives and are strongly advocating for the continuation of w4i and Austrian participation in KHAN-II. Read the full statement here: https://lnkd.in/dNz7CNmV #Uniko #AustrianUniversities #w4i #KHAN #technologytransfer #innovation #funding #Research #Collaboration

Check out todays LISA - Life Science Austria highlight of wings4innovation GmbH managing director Peter Nussbaumer and his take on the #lifescience sector in #Austria #technologytransfer #drugdiscovery KHAN Technology Transfer Fund I

📢 xbio is now open for applications 📢 Embark on your entrepreneurial journey with the second edition of xbio! #SecondCohort Join this intensive 11-week biotech enterprise masterclass designed to equip you with the knowledge, skills, and network needed to kickstart your biotech venture. Ready to take the plunge? Apply now at www.x-bio.at ! Application deadline is March 15th. xbio is jointly presented by #ISTA Institute of Science and Technology Austria , xista science ventures , xista innovation , Österreichische Akademie der Wissenschaften , Technische Universität Wien , Medical University of Vienna , Universität Wien , Vetmeduni , wings4innovation GmbH , KHAN Technology Transfer Fund I , Austria Wirtschaftsservice , INiTS | Vienna's High-Tech Incubator , AIT Austrian Institute of Technology , CeMM , Institute of Molecular Biotechnology , Gregor Mendel Institute , WU (Vienna University of Economics and Business) #xbio #CallforApplications #BiotechEntrepreneurship #StartupJourney #Founders #InnovationInBiotech

Check out our latest company highlight in the news feed of LISA - Life Science Austria : As a subsidiary of KHAN Technology Transfer Fund I (KHAN-I), w4i's mission is to uncover and advance promising, innovative #drugdiscovery projects originating from basic research. Our collaborative platform supports scientists in overcoming financial and logistical challenges, advancing innovations on the road from concept to patients and market. ✨ What we offer: * Support for innovative drug discovery projects * Collaborative efforts with academic proposers * Focus on therapeutic areas lacking medical solutions 🌐 Our Team's Approach: Leveraging networks in academia and industry, #w4i ensures a professional evaluation and platform for innovative drug discovery projects. KHAN-I and w4i facilitate partnerships, support key development steps, and contribute to Austria's international life science competitiveness. 🎯 Achievements: * Framework agreement with 20 Austrian research institutions * Reviewed over 120 proposals * Successfully proposed 8 drug discovery projects and 1 company investment for KHAN-I financing * Collaboration with Lead Discovery Center GmbH for professional support Explore more at w4i.org and khanu.de . For inquiries, contact info@w4i.org . Read the full article here: https://lnkd.in/dT-jH7Sr Special thanks go to Gernot Faustmann and Liesa Doppler Let's soar together! 🚀 #Wings4Innovation #drugdiscovery #LifeScienceInAustria #technologytransfer #LISA

🎄✨ Wishing You Happy Holidays from wings4innovation GmbH! ✨🎄 May this festive season bring you joy and warmth! Here's to celebrating the spirit of innovation and to scientific achievements in the coming year! KHAN Technology Transfer Fund I wings4innovation GmbH #merrychristmas #happynewyear #technologytransfer #fundingopportunity

Metric
Company Name	Wings 4 Innovation	Optilingua	IoThink Solutions	Lead Discovery Center
Symbol
MSH ID	ORG:W4I	COM:ALPHATRAD	COM:IOTHINK-SOLUTIONS	DE:LEAD-DISCOVERY
Market	PRIVATE	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Commercial & Professional Services	Technology	Healthcare & Health Services
Industry	Biotechnology	Translation Services	Internet of Things (IoT)	Biotechnology
Country	AT	DE	FR	DE
Stage
Employee Count
Website	w4i.org	alphatrad.com	iothink-solutions.com	lead-discovery.de
LinkedIn	wings4innovation-gmbh		iothink-solutions	lead-discovery-center-gmbh
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	5.84K	677
Web Traffic Growth	2.12	-0.44
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

W4I

ORG:W4I

Wings 4 Innovation

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue